In collaboration with Google  NASDAQ GOOGL  Cloud, Ginkgo is developing AI models that incorporate its proprietary metagenomics data, which could form the basis for additional pharmaceutical partnerships in 2024.This news is based on a press release statement from Ginkgo Bioworks.
Ginkgo Bioworks is collaborating with Google Cloud to develop AI models using Ginkgo's metagenomics data, potentially leading to new pharmaceutical partnerships in 2024.